JP5771123B2 - プロフィラグリンｃ末端ドメイン特異的抗体及びその用途 - Google Patents

プロフィラグリンｃ末端ドメイン特異的抗体及びその用途 Download PDF

Info

Publication number
JP5771123B2
JP5771123B2 JP2011245483A JP2011245483A JP5771123B2 JP 5771123 B2 JP5771123 B2 JP 5771123B2 JP 2011245483 A JP2011245483 A JP 2011245483A JP 2011245483 A JP2011245483 A JP 2011245483A JP 5771123 B2 JP5771123 B2 JP 5771123B2
Authority
JP
Japan
Prior art keywords
terminal domain
gene
filaggrin
abnormality
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2011245483A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013100249A (ja
JP2013100249A5 (OSRAM
Inventor
利彦 日比野
利彦 日比野
真実 山本
真実 山本
雅哉 ▲高▼木
雅哉 ▲高▼木
純一 坂部
純一 坂部
新樹 戸倉
新樹 戸倉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2011245483A priority Critical patent/JP5771123B2/ja
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to CN201280066201.0A priority patent/CN104039827B/zh
Priority to HK15102350.3A priority patent/HK1201856B/xx
Priority to KR1020147011999A priority patent/KR102025446B1/ko
Priority to EP12848401.1A priority patent/EP2778174B1/en
Priority to PCT/JP2012/079015 priority patent/WO2013069741A1/ja
Priority to US14/356,985 priority patent/US20140287431A1/en
Priority to ES12848401.1T priority patent/ES2650733T3/es
Publication of JP2013100249A publication Critical patent/JP2013100249A/ja
Publication of JP2013100249A5 publication Critical patent/JP2013100249A5/ja
Application granted granted Critical
Publication of JP5771123B2 publication Critical patent/JP5771123B2/ja
Priority to US16/136,929 priority patent/US20190079080A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/202—Dermatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2011245483A 2011-11-09 2011-11-09 プロフィラグリンｃ末端ドメイン特異的抗体及びその用途 Active JP5771123B2 (ja)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP2011245483A JP5771123B2 (ja) 2011-11-09 2011-11-09 プロフィラグリンｃ末端ドメイン特異的抗体及びその用途
ES12848401.1T ES2650733T3 (es) 2011-11-09 2012-11-08 Anticuerpo específico para el dominio C-terminal de la profilagrina y su uso
KR1020147011999A KR102025446B1 (ko) 2011-11-09 2012-11-08 프로필라그린 c 말단 도메인 특이적 항체 및 그의 용도
EP12848401.1A EP2778174B1 (en) 2011-11-09 2012-11-08 Antibody specific to profilaggrin c-terminal domain, and use thereof
PCT/JP2012/079015 WO2013069741A1 (ja) 2011-11-09 2012-11-08 プロフィラグリンc末端ドメイン特異的抗体及びその用途
US14/356,985 US20140287431A1 (en) 2011-11-09 2012-11-08 Antibody specific to profilaggrin c-terminal domain, and use thereof
CN201280066201.0A CN104039827B (zh) 2011-11-09 2012-11-08 丝聚合蛋白原c末端结构域特异性抗体及其用途
HK15102350.3A HK1201856B (en) 2011-11-09 2012-11-08 Antibody specific to profilaggrin c-terminal domain, and use thereof
US16/136,929 US20190079080A1 (en) 2011-11-09 2018-09-20 Antibody specific to profilaggrin c-terminal domain, and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011245483A JP5771123B2 (ja) 2011-11-09 2011-11-09 プロフィラグリンｃ末端ドメイン特異的抗体及びその用途

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014014846A Division JP5943945B2 (ja) 2014-01-29 2014-01-29 プロフィラグリンｃ末端ドメイン特異的抗体及びその用途

Publications (3)

Publication Number Publication Date
JP2013100249A JP2013100249A (ja) 2013-05-23
JP2013100249A5 JP2013100249A5 (OSRAM) 2013-08-08
JP5771123B2 true JP5771123B2 (ja) 2015-08-26

Family

ID=48290111

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011245483A Active JP5771123B2 (ja) 2011-11-09 2011-11-09 プロフィラグリンｃ末端ドメイン特異的抗体及びその用途

Country Status (7)

Country Link
US (2) US20140287431A1 (OSRAM)
EP (1) EP2778174B1 (OSRAM)
JP (1) JP5771123B2 (OSRAM)
KR (1) KR102025446B1 (OSRAM)
CN (1) CN104039827B (OSRAM)
ES (1) ES2650733T3 (OSRAM)
WO (1) WO2013069741A1 (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
WO2020076770A1 (en) * 2018-10-08 2020-04-16 Yale University Selective binding and aggregation of human keratin in the skin barrier using human filaggrin subdomains sd67 and sd150

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992019649A1 (fr) * 1991-04-26 1992-11-12 Clonatec Antigenes reconnus par des anticorps de la polyarthrite rhumatoide, leur preparation et leurs applications
JP5039544B2 (ja) * 2004-06-18 2012-10-03 ジェネンテック， インコーポレイテッド 腫瘍の治療
GB0525492D0 (en) * 2005-12-15 2006-01-25 Univ Dundee Filaggrin
JP2007217325A (ja) * 2006-02-16 2007-08-30 Kose Corp プロフィラグリン及び／又はフィラグリン産生促進剤
JP5858788B2 (ja) * 2009-12-03 2016-02-10 株式会社 資生堂 ブレオマオシン水解酵素の活性を指標としたアトピー性皮膚炎による乾燥肌改善剤のスクリーニング方法

Also Published As

Publication number Publication date
CN104039827B (zh) 2016-12-14
US20190079080A1 (en) 2019-03-14
KR20140089366A (ko) 2014-07-14
EP2778174A1 (en) 2014-09-17
EP2778174A4 (en) 2015-06-24
EP2778174B1 (en) 2017-11-01
ES2650733T3 (es) 2018-01-22
JP2013100249A (ja) 2013-05-23
HK1201856A1 (en) 2015-09-11
CN104039827A (zh) 2014-09-10
WO2013069741A1 (ja) 2013-05-16
KR102025446B1 (ko) 2019-09-25
US20140287431A1 (en) 2014-09-25

Similar Documents

Publication Publication Date Title
Nguyen et al. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris–like lesions
Di Zenzo et al. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid
US7803553B2 (en) Methods of use of antibodies which recognize a protease cleavage site of an LAP fragment of TGF-β
WO2005052593A1 (en) Detection
CA2105903A1 (en) Methods and compositions for the detection of soluble .beta.-amyloid peptide
JP2014521098A (ja) 病理学バイオマーカーアッセイ
Barascuk et al. A MMP derived versican neo-epitope is elevated in plasma from patients with atherosclerotic heart disease
US20190079080A1 (en) Antibody specific to profilaggrin c-terminal domain, and use thereof
CN103183726B (zh) 衍生自人bplp蛋白的肽、编码所述肽的多核苷酸和针对所述肽的抗体
JPH11242026A (ja) 腎疾患の検査方法
JP5943945B2 (ja) プロフィラグリンｃ末端ドメイン特異的抗体及びその用途
RU2739607C2 (ru) Специфически очищенные антитела против пресепсина
ES2367131T3 (es) Anticuerpos y antígenos peptídicos para la producción de anticuerpos que tienen una especificidad de unión selectiva para la hormona paratiroidea (pth) 1-84 intacta bioactiva.
Chen et al. High expression level of homocitrulline is correlated with seborrheic keratosis and skin aging
JP2011226882A (ja) 泌尿器系疾患マーカー及びその抗体、並びに泌尿器系疾患診断用キット
JP5961608B2 (ja) ＥｐｈＡ４細胞外ドメインの測定による認知機能障害を伴う神経系疾患の検出方法
JP4560314B2 (ja) 中性アミノ酸トランスポーターによる癌の検出法、及びそのためのキット
EP2918600A1 (en) Novel peptide and use thereof
HK1201856B (en) Antibody specific to profilaggrin c-terminal domain, and use thereof
JP2648952B2 (ja) 種々の病理的状態に於いてｐｓ２遺伝子から特異的に発現される蛋白質及びその断片、該蛋白質及び／又はその断片から得られる抗体、並びに病理的状態に対する検出、診断及び治療への該蛋白質、その断片及び抗体の適用
CN112724236B (zh) 一种两性蛋白1的抗原肽及其抗体与应用
JP6183920B2 (ja) 腎炎の病変部位の検査方法およびそのための試薬
JP5354158B2 (ja) 抗デカン酸修飾型グレリン抗体、デカン酸修飾型グレリン測定方法、およびデカン酸修飾型グレリン分離回収方法
JP2007316009A (ja) アドレノメデュリン前駆体ｃ末端ペプチドの濃度の上昇を指標として循環器疾患又は炎症性疾患を診断する方法
HK1135184B (en) Biomarkers for inflammation of the liver

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130607

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130607

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20130607

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20130710

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130723

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20131029

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20140128

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140129

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20140128

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20140414

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20140606

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150202

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150527

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150626

R150 Certificate of patent or registration of utility model

Ref document number: 5771123

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250